Genetic Testing Market 2031 | Research Report, Size, Share, Analysis, Demand by Forecast
Genetic Testing Market Overview:
The global genetic testing market is anticipated to expand at a
compound annual growth rate (CAGR) of approximately 10% during the forecast
period. Market growth is driven by the rising prevalence of genetic disorders,
increasing emphasis on early and preventive healthcare, growing demand for
direct-to-consumer (DTC) genetic tests, and the expanding use of genetic
testing in oncology.
Download Sample Copy: https://meditechinsights.com/genetic-testing-market/request-sample/
Genetic testing is a medical diagnostic procedure used to identify
changes or abnormalities in genes, chromosomes, or proteins. Test results help
confirm or rule out suspected genetic conditions and support the assessment of
an individual’s risk of developing or passing on inherited disorders. Genetic
testing encompasses several key categories:
- Diagnostic Testing: Used to confirm genetic
conditions in symptomatic individuals, such as cystic fibrosis or
Huntington’s disease.
- Presymptomatic and Predictive
Testing: Evaluates genetic risk before symptoms appear, particularly
valuable for individuals with a family history of diseases such as
hereditary colorectal cancers.
- Carrier Testing: Conducted prior to family
planning, especially for individuals from high-risk ethnic groups or with
a family history of genetic disorders. It identifies carrier status in
prospective parents.
- Pharmacogenetic Testing: Enables personalized medication
selection and dosage optimization based on an individual’s genetic
profile, improving treatment outcomes.
- Prenatal Testing: Detects genetic abnormalities
during pregnancy, including conditions such as Down syndrome and Trisomy
18, using conventional screening methods or advanced cell-free DNA
testing.
- Newborn Screening: Mandatory testing performed
shortly after birth to identify conditions such as congenital
hypothyroidism, sickle cell disease, and phenylketonuria (PKU), enabling
timely medical intervention.
- Preimplantation Genetic Testing: Used during in-vitro
fertilization (IVF), where preimplantation genetic diagnosis (PGD) screens
embryos for genetic abnormalities to improve pregnancy success rates.
Genetic Testing’s Role in Disease
Detection Driving Market Growth
Genetic testing, including prenatal and newborn screening, plays a vital
role in identifying disorders such as thalassemia, Down syndrome, and cystic
fibrosis. The increasing global incidence of genetic diseases is expected to
significantly boost demand for genetic testing. According to the United
Nations, approximately 3,000 to 5,000 children are born annually with Down
syndrome worldwide. Data from the Cystic Fibrosis Foundation indicate that
around 40,000 individuals in the United States live with cystic fibrosis, with
approximately 1,000 new cases diagnosed each year. Additionally, the Indian
Academy of Thalassemia reported that nearly 15,000 children are born with
thalassemia annually in India, accounting for roughly 10% of global pediatric
cases.
Download Sample Copy: https://meditechinsights.com/genetic-testing-market/request-sample/
Rising Focus on Early and Preventive
Care Fuels Demand
The growing emphasis on early diagnosis and preventive healthcare is a
major driver of genetic testing adoption, particularly in the United States.
Escalating healthcare costs associated with chronic disease management have
encouraged healthcare systems and policymakers to prioritize early risk
assessment. Cardiovascular diseases alone account for an estimated USD 320
billion annually in direct and indirect healthcare costs in the U.S. Genetic
testing enables early identification of health risks, allowing for timely
intervention and disease prevention. As a result, many private healthcare
payers now include genetic testing within reimbursement frameworks, further
supporting market growth. Increased coverage for rare disease testing has also
contributed to broader adoption.
Competitive Landscape
The genetic testing market is highly competitive, with key players
including Abbott Laboratories, Danaher Corporation, Thermo Fisher Scientific,
Hoffmann-La Roche, QIAGEN, Illumina, Myriad Genetics, Bio-Rad Laboratories,
DiaSorin/Luminex Corporation, CircleDNA, tellmeGen, 23andMe, AncestryDNA,
Mapmygenome, Color Health, and MyHeritage, among others.
Browse Report: https://meditechinsights.com/genetic-testing-market/
Strategic Initiatives Driving Market
Expansion
Market participants are actively pursuing organic and inorganic growth
strategies, such as product innovation, partnerships, and acquisitions, to
strengthen their market presence and expand customer reach. Notable
developments include:
- In June 2022, Prenetics Group
Limited launched ColoClear by Circle, a non-invasive at-home screening
test for early detection of colorectal cancer.
- In March 2022, Illumina
introduced a comprehensive genomic profiling test for cancer in Europe,
capable of analyzing multiple tumor genes and biomarkers through a single
assay.
- In November 2022, Myriad Genetics
acquired Gateway Genomics, integrating consumer-focused genetic testing
solutions, including the SneakPeek Early Gender DNA Test, into its
portfolio.
Looking ahead, the genetic testing market is expected to gain further
traction due to the increasing adoption of next-generation sequencing
technologies, rising disposable incomes, continuous technological advancements,
expanding test availability, and aggressive growth strategies implemented by
industry players.
Related Report:
HPV Testing and PAP Test Market - https://www.pharmiweb.com/press-release/2025-12-18/hpv-testing-and-pap-test-market-share-size-growth-forecast-till-2030
Cellular Health Screening Market - https://www.pharmiweb.com/press-release/2025-12-18/cellular-health-screening-market-2030-analysis-size-share-growth-trends-and-forecast
Hematology Market - https://www.pharmiweb.com/press-release/2025-12-18/hematology-market-outlook-2030-industry-trends-and-competitive-analysis
Long-Term Care Software Market - https://www.pharmiweb.com/press-release/2025-12-18/long-term-care-software-market-demand-for-evidence-based-medicine-and-research-updates
About Medi-Tech Insights;
Medi-Tech Insights is a healthcare-focused business research
& insights firm. Our clients include Fortune 500 companies, blue-chip
investors & hyper-growth start-ups. We have completed 100+ projects in
Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma
Services in the areas of market assessments, due diligence, competitive intelligence,
market sizing and forecasting, pricing analysis & go-to-market strategy.
Our methodology includes rigorous secondary research combined with deep-dive
interviews with industry-leading CXO, VPs, and key demand/supply side
decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
Comments
Post a Comment